Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Conference News SCAI 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

L.A. McKeown

May 22, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

Medtronic Recalls IN.PACT Admiral and IN.PACT AV Catheters

L.A. McKeown

March 31, 2022

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Top Coronary Artery Disease News in 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

TCTMD’s Top 10 Most Popular Stories for June 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Medtronic Recalls IN.PACT Admiral and IN.PACT AV Catheters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content